NASDAQ (USD): Pear Therapeutics, Inc. (PEARW)
Last Price
0.006
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Cash from operating activities
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
12
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Meta Launches Generative AI Video Tools for Advertisers
2
Fed Vice-chair Says Risks to Inflation, Employment Now Balanced
3
FTX Creditors Emerge as Possible Fillip for Ailing Crypto Market
4
OpenAI Starts Hiring in Singapore for Second Office in Asia
5
Rio Tinto Expands Lithium Bet With Biggest Deal Since 2007
#
Stock
Score
PLTR
Palantir Technologies Inc.
BABA
Alibaba Group Holding Limited
AMD
Advanced Micro Devices, Inc.
750
AAPL
Apple Inc.
MSFT
Microsoft Corporation
550
6
ETE
500
7
T
AT&T Inc.
8
SXCP
9
TYL
Tyler Technologies, Inc.
10
CUBE
CubeSmart
Last
Change
Volume
JTAI
0.11
+0.028
284,423,878
CDT
0.119
+0.016
254,584,161
LUXH
0.06
+0.01
136,778,247
LMDX
0.016
-0.018
120,553,903
NVDA
135.14
+0.335
100,332,351
TWG
6.05
+3.94
97,820,742
TSLA
220.49
-18.28
91,660,445
TSLL
9.67
-1.74
90,619,027
762.00
-84.71
85,558,284
SQQQ
7.16
-0.04
57,445,387
BRK-A
691,598.00
+9,128.00
901
NVR
9,583.61
+98.06
1,975
MELI
2,103.26
+62.76
115,630
GWW
1,081.66
+56.50
171,586
TPL
1,046.77
+44.57
38,758
TDG
1,404.16
+35.18
52,536
AZO
3,138.99
+32.439
18,326
FICO
2,016.60
+32.08
30,238
BLK
985.63
+30.04
452,888
FCNCA
2,021.09
+24.36
21,432
1,629.32
-188.66
1,851,535
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
MPWR
838.63
-96.05
902,546
NOW
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
OLED
172.28
-40.39
1,254,445
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....